Sartorius Stedim Biotech SA (OTCPK:SDMHF)
$ 220 0 (0%) Market Cap: 21.58 Bil Enterprise Value: 25.42 Bil PE Ratio: 60.71 PB Ratio: 7.62 GF Score: 97/100

Q3 2021 Sartorius AG Earnings Call Transcript

Oct 20, 2021 / 01:30PM GMT
Release Date Price: $546.43
Operator

Good day, and welcome to the Sartorius and Sartorius Stedim Biotech Conference Call on the 9 months 2021 results. Today's conference is being recorded.

At this time, I would like to turn the conference over to Dr. Joachim Kreuzburg, CEO. Please go ahead.

Joachim Kreuzburg
Sartorius Aktiengesellschaft - Chairman of Executive Board & CEO

Thank you very much, and good day, everybody. Welcome to our conference call on our 9 months results for 2021 for both the Sartorius Group as well as for the Sartorius Stedim Biotech Group. We would like to kick it off by taking you though the Sartorius AG, Sartorius Group's numbers first and then directly after that through the results for Sartorius Stedim Biotech, and then we open the line for Q&A.

Before I hand over to Rainer, our CFO, I would like to just highlight the most important results of the first 9 months in 2021. Both divisions continue to have very -- to show a very dynamic double-digit growth in both order intake as well sales revenue, pretty much as expected, I would say, in Q3 then in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot